Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)

NCT: NCT06670651 · ENROLLING_BY_INVITATION

NCT IDNCT06670651
StatusENROLLING_BY_INVITATION
Start Date2025-03-21
Completion2031-12
SponsorLinkBio Corp. (INDUSTRY)
First posted
Last updated

Brief Summary

To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.

Frequently Asked Questions

What is LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)?

LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC) is a clinical trial registered under NCT06670651. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06670651?

The current status of NCT06670651 (LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)) is: ENROLLING_BY_INVITATION.

When did LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC) start?

LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC) started on 2025-03-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.